Literature DB >> 12580895

Randomized clinical trial of the efficacy and safety of tropicamide and phenylephrine in preoperative mydriasis for phacoemulsification.

Philip T H Lam1, Betty T M Poon, Wai-Kwan Wu, Stanley C C Chi, Dennis S C Lam.   

Abstract

PURPOSE: To compare the mydriatic effect and safety between different concentrations of tropicamide and phenyle-phrine in preoperative mydriasis for phaco-emulsification.
METHODS: Two hundred and seventeen consecutive eyes in the same number of Chinese patients undergoing phaco-emulsification under local or topical anaesthesia in a university-based eye hospital were analyzed. Patients were randomized into two groups by cluster randomization, each group receiving a different preoperative mydriatic regimen. Regimen A consisted of tropicamide 1.0% with phenylephrine 2.5%, and Regimen B consisted of tropicamide 0.5% with phenylephrine 0.5%. The main outcome measures were horizontal pupillary diameter, systolic, diastolic and pulse pressure and pulse rate.
RESULTS: The group who received Regimen A attained a mean horizontal pupillary diameter of 7.00 +/- 1.06 mm. Their pupils were significantly larger than those receiving Regimen B (6.61 +/- 1.03 mm, P = 0.007). No untoward cardiovascular effects were noted in either groups.
CONCLUSION: Regimen A attained better preoperative mydriasis for phacoemulsification than Regimen B. Both regimens were safe with regard to their cardiovascular effects. The combination of tropicamide 1.0% and phenylephrine 2.5% is recommended as preoperative mydriatic for phacoemulsification in Chinese patients who have darkly pigmented irides.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580895     DOI: 10.1046/j.1442-9071.2003.00600.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  6 in total

1.  The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study.

Authors:  Rana Altan-Yaycioglu; Ozgur Yaycioglu; Umit Gul; Aysel Pelit; Fatih M Adibelli; Yonca A Akova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-16       Impact factor: 3.000

Review 2.  Potential cardiovascular adverse events when phenylephrine is combined with paracetamol: simulation and narrative review.

Authors:  Hartley C Atkinson; Amanda L Potts; Brian J Anderson
Journal:  Eur J Clin Pharmacol       Date:  2015-05-29       Impact factor: 2.953

Review 3.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03

4.  Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.

Authors:  Patama Bhurayanontachai; Suwapat Saengkaew; Penjamaporn Apiromruck
Journal:  J Optom       Date:  2016-06-16

5.  Safety of tropicamide and phenylephrine in pupillary mydriasis for cataract surgery.

Authors:  Sikander A K Lodhi; Manjula V Ramsali; Dilip K Kulkarni; P Surender; Srinivasa Murty
Journal:  Saudi J Ophthalmol       Date:  2022-02-18

6.  Phacoemulsification without preoperative topical mydriatics: induction and sustainability of mydriasis with intracameral mydriatic solution.

Authors:  Sanjiv K Gupta; Ajai Kumar; Swati Agarwal; Siddarth Agarwal
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.